Hyperfine adds BTIG to $50 million stock offering program

Hyperfine Inc. (NASDAQ: HYPR) entered into an amended sales agreement on December 29, 2025, adding BTIG, LLC as an additional sales agent to its at-the-market offering program, according to a company statement.

The medical device company can now sell up to $50 million in Class A common stock through both B. Riley Securities, Inc. and BTIG as sales agents. The amended agreement updates the original sales agreement with B. Riley from November 9, 2023, with no other material terms changed.

Under the program, Hyperfine may sell shares at its discretion through methods deemed "at the market offerings" as defined by Securities Act Rule 415. The sales agents will use commercially reasonable efforts to sell shares based on company instructions, including price, time or size limits.

Hyperfine will pay the sales agents a commission of up to 3.0% of gross sales proceeds from any shares sold under the agreement. The company has also provided the agents with indemnification and contribution rights.

The company is not obligated to sell any shares under the agreement. The offering program will end when all shares are sold or the agreement is terminated according to its terms.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• Interactive Brokers adds nine crypto tokens and stablecoin withdrawals
• ONAR Holding regains SEC reporting status, posts revenue gains